Company: BSX
Filing Date: 2025-02-24
Form Type: 424B2
Source: 0001104659-25-016521
Chunk: 67

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-02-24
Form: 424B2
Chunk 67
---
 | ​ | ​                                    | ​ |  27,300,000 | ​ | ​ |
| MUFG Securities (Europe) N.V.                    | ​ | ​ | ​                                    | ​ |  13,600,000 | ​ | ​ | ​ | ​                                    | ​ |  10,400,000 | ​ | ​ |
| Total                                            | ​ | ​ | ​                                    | € | 850,000,000 | ​ | ​ | ​ | ​                                    | € | 650,000,000 | ​ | ​ |

The underwriters have agreed to purchase all of the notes sold pursuant to the underwriting agreement if any of the notes are purchased. If an underwriter defaults, the underwriting agreement provides that the purchase commitments of the non-defaulting underwriters may be increased or the underwriting agreement may be terminated. We have agreed to indemnify the underwriters against certain liabilities, including liabilities under the Securities Act, or to contribute to payments the underwriters may be required to make in respect of those liabilities. The underwriters are offering the notes, subject to prior sale, when, as and if issued to and accepted by them, subject to approval of legal matters by their counsel, including the validity of the notes, and other conditions contained in the underwriting agreement, such as the receipt by the underwriters of officer’s certificates and legal opinions. The underwriters reserve the right to withdraw, cancel or modify offers to the public and to reject orders in whole or in part. To the extent any underwriter that is not a U.S. registered broker-dealer intends to effect any offers or sales of any notes in the United States, it will do so through one or more U.S. registered broker-dealers in accordance with the applicable U.S. securities laws and regulations. Commissions and Discounts The underwriters have advised us that they propose to offer the notes to the public at the public offering prices set forth on the cover page of this prospectus supplement. After the initial public offering, the public offering prices and discounts may be changed.

S-36

TABLE OF CONTENTS

The expenses of the offering, not including the underwriting discounts, are estimated to be $5.1 million and are payable by us.

#### New Issue of Notes
Application will be made for the notes to be admitted to the Official List of Euronext Dublin and to trading on the Global Exchange Market thereof. The listing application will be subject to approval by Euronext Dublin. Upon such listing, we will